Presence of natural killer-cell clones with variable proliferative capacity in chronic active Epstein-Barr virus infection

被引:17
作者
Nagata, H
Numata, T
Konno, A
Mikata, I
Kurasawa, K
Hara, S
Nishimura, M
Yamamoto, K
Shimizu, N
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Virol, Div Virol & Immunol,Bunkyo Ku, Tokyo 1138510, Japan
[2] Chiba Univ, Sch Med, Dept Otorhinolaryngol, Chiba 280, Japan
[3] Narita Red Cross Hosp, Dept Pathol, Narita, Japan
[4] Chiba Univ, Sch Med, Dept Internal Med 2, Chiba 280, Japan
关键词
cell line; Epstein-Barr virus; lymphoma; natural killer cell; transformation;
D O I
10.1046/j.1440-1827.2001.01276.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Chronic active Epstein-Barr virus infection (CAEBV) is a syndrome that takes diverse clinical courses and is often associated with lymphoproliferative disorders of T/natural killer (NK)-cell lineage. We describe a patient with CAEBV associated with persistent pharyngeal ulcer, and with subsequent nasal T/NK-cell lymphoma in her neck lymph nodes and nasopharynx. Immunophenotyping of lymphoid cells showed that the lineage of Epstein-Barr virus (EBV)-positive cells in the patient was of NK-cell origin. By means of high-dose recombinant interleukin-2, we established an EBV-positive cell line of NK-cell lineage from her peripheral blood. Southern blot analysis for the number of terminal repeat sequences of EBV detected three NK-cell clones in the patient's lymph node. One of these clones was identical to the established cell line but was not observed in the pharyngeal ulcer, while the other two clones were present in the pharyngeal ulcer. These results suggest that the patient had expansion of the three NK-cell clones, one of which had proliferative capacity in vitro and was involved in the formation of the lymphoma. Moreover, the results suggest that the proliferative capacity of EBV-positive cells can be variable even in a single patient, and this variability may explain the clinical diversity in CAEBV.
引用
收藏
页码:778 / 785
页数:8
相关论文
共 41 条
[1]   MORPHOLOGY, IMMUNOPHENOTYPE, AND DISTRIBUTION OF LATENTLY AND/OR PRODUCTIVELY EPSTEIN-BARR VIRUS-INFECTED CELLS IN ACUTE INFECTIOUS-MONONUCLEOSIS - IMPLICATIONS FOR THE INTERINDIVIDUAL INFECTION ROUTE OF EPSTEIN-BARR-VIRUS [J].
ANAGNOSTOPOULOS, I ;
HUMMEL, M ;
KRESCHEL, C ;
STEIN, H .
BLOOD, 1995, 85 (03) :744-750
[2]  
Chang K L, 1992, Diagn Mol Pathol, V1, P246, DOI 10.1097/00019606-199203000-00037
[3]  
Chiang AKS, 1997, INT J CANCER, V73, P332, DOI 10.1002/(SICI)1097-0215(19971104)73:3<332::AID-IJC5>3.0.CO
[4]  
2-0
[5]  
CLEARY ML, 1988, BLOOD, V72, P349
[6]  
Fujieda Mikiya, 1993, Acta Paediatrica Japonica (Overseas Edition), V35, P394
[7]   CD3-NEGATIVE LYMPHOPROLIFERATIVE DISEASE OF GRANULAR LYMPHOCYTES IN A GIRL WITH AN UNUSUAL PATTERN OF ANTI-EPSTEIN-BARR VIRUS-ANTIBODIES [J].
FUKUNAGA, Y ;
ASANO, T ;
TAKEHANA, J ;
AMBO, K ;
MATSUOKA, K ;
YAMAMOTO, M .
EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (12) :894-897
[8]   EPSTEIN-BARR VIRUS (EBV) INDUCED POLYCLONAL AND MONOCLONAL B-CELL LYMPHOPROLIFERATIVE DISEASES OCCURRING AFTER RENAL-TRANSPLANTATION - CLINICAL, PATHOLOGIC, AND VIROLOGIC FINDINGS AND IMPLICATIONS FOR THERAPY [J].
HANTO, DW ;
GAJLPECZALSKA, KJ ;
FRIZZERA, G ;
ARTHUR, DC ;
BALFOUR, HH ;
MCCLAIN, K ;
SIMMONS, RL ;
NAJARIAN, JS .
ANNALS OF SURGERY, 1983, 198 (03) :356-369
[9]   Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection [J].
Imai, S ;
Sugiura, M ;
Oikawa, O ;
Koizumi, S ;
Hirao, M ;
Kimura, H ;
Hayashibara, H ;
Terai, N ;
Tsutsumi, H ;
Oda, T ;
Chiba, S ;
Osato, T .
BLOOD, 1996, 87 (04) :1446-1457
[10]   CHRONIC ACTIVE EPSTEIN-BARR-VIRUS INFECTION IN CHILDREN IN JAPAN [J].
ISHIHARA, S ;
OKADA, S ;
WAKIGUCHI, H ;
KURASHIGE, T ;
MORISHIMA, T ;
KAWAHA, K .
ACTA PAEDIATRICA, 1995, 84 (11) :1271-1275